Glaxo's diabetes drug beats older rivals

Diabetes :: Glaxo's diabetes drug beats older rivals

Diabetes patients starting out on GlaxoSmithKline drug Avandia have a better chance of keeping blood sugar levels within safe limits than those given older medicines, revealed after a clinical trial by Glaxo.

A clinical trial tracking patients for up to five years found the right medicines could slow the progress of type 2 diabetes significantly, holding out the prospect of better treatment.

Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia? (rosiglitazone maleate) reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin (p<0.001), and 63 percent compared to glyburide (p<0.001) at five years.

The results of this international study involving 4,360 people recently diagnosed with type 2 diabetes were today published in the New England Journal of Medicine and presented at the 19th World Diabetes Congress of the International Diabetes Federation (IDF).




(Diabetes :: Glaxo's diabetes drug beats older rivals published at SpiritIndia on Tuesday, December 5, 2006)

Diabetes

Search more information on Diabetes, Diabetes books

Recently posted related articles on Diabetes :

1. Diabetes :: 63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes
2. Diabetes :: India to launch special programme to control diabetes
3. Diabetes :: Stanford researchers shed light on gestational diabetes
4. Diabetes :: The new source of islet cells
5. Diabetes :: European Medicine Agency confirms positive Avandia benefit risk assessment
6. Pancreatitis :: Diabetes drug Byetta, exenatide may cause acute pancreatitis
7. Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate
8. Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes
9. Diabetes :: New IDF guidelines raise importance of post-meal glucose control
10. Diabetes :: Solving a critical part of the insulin puzzle

Most related articles:

- Diabetes :: Glaxo's diabetes drug beats older rivals
- Avandia :: FDA Advisory Panel supports Glaxo's diabetes drug Avandia - 8.6
- Avandia :: Keep GSK diabetes drug Avandia available to US patients - 8.5
- Diabetes :: World Diabetes Day - November 14 - Australia - 8.4
- Diabetes :: New blood pressure medicines are less diabetes risky - 8.2
- Diabetes :: Gestational diabetes raises future diabetes risk - 8.1
- Diabetes :: Alfalfa and Diabetes - 8.1
- Diabetes :: Older Diabetes Drugs Have Similar or Superior Effects to Newer, Pricier Medications - 8
- Diabetes :: Lifestyle changes effective in protecting against Type II diabetes - 7.9
- Diabetes :: Lifestyle changes effective in protecting against Type II Diabetes - 7.8

Diabetes - recent related articles/news stories:

- Gene Deaf1 may play a role in type 1 diabetes
- Pancreatic cancer risk reduced by diabetes drug metformin
- Low birth weight linked to diabetes gene CDKAL1
- Treating obesity with brown fat in the body
- Antipsychotics raise blood sugar in older diabetes patients

»»   Rich :: Richest 2 percent own half world wealth
««   NHS :: NHS Plan for A&E cuts

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com